Blood News and Research

RSS

Successful delivery after womb transplant

A Brazilian woman became the first woman to successfully deliver a baby after having received a womb transplant from a dead donor.

4 Dec 2018

Cancer cells could be detected irrespective of site and type using simple test

Australian researchers have found that cells containing cancer could soon be detected using a simple test. The test could one day change how cancers are diagnosed, the team says. The results of the study to develop the test were published in the journal Nature Communications.

4 Dec 2018

Single workout can improve metabolism for up to 2 days

Lounging around all weekend may weigh heavy on the minds of the health conscious. But these sedentary stretches may not affect the waistline, provided they're preceded by a bit of exercise.

4 Dec 2018

Advances in gene therapy for inherited blood disorders

Gene therapy holds a lot of promise in medicine. If we could safely alter our own DNA, we might eliminate diseases our ancestors passed down to us.

4 Dec 2018

Study of infrequent cannabis users compares adverse effects of vaping and smoking

In a small study of infrequent cannabis users, Johns Hopkins Medicine researchers have shown that, compared with smoking cannabis, vaping it increased the rate of short-term anxiety, paranoia, memory loss and distraction when doses were the same.

4 Dec 2018

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

A Vanderbilt University Medical Centerstudy published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor in combination with an oral anticoagulant.

4 Dec 2018

Cancer DNA signature will revolutionize point-of-care diagnostics

Researchers have developed a potentially game-changing new technology that could revolutionize cancer point-of-care (POC) diagnostics.

4 Dec 2018

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

4 Dec 2018

Researchers find two connective tissue cells to be linked to worse prognosis of breast cancer

In certain forms of cancer, connective tissue forms around and within the tumor. One previously unproven theory is that there are several different types of connective tissue cells with different functions, which affect the development of the tumor in different ways.

4 Dec 2018

Scientists find link between dietary salt intake and risk of developing common heart condition

Scientists have uncovered the first evidence to associate dietary salt intake with the risk of developing a common heart condition that affects millions of people worldwide, in a new study published in the Annals of Medicine.

4 Dec 2018

NanoBioCel group develops lipid vesicles that can genetic material efficiently and viably

In a piece of research conducted in collaboration, the NanoBioCel group of the UPV/EHU's Faculty of Pharmacy, and the University of Elche have designed some niosomes, which are lipid vesicles for use in gene therapies designed to treat diseases of the central nervous system.

4 Dec 2018

In grandma’s stocking: An apple watch to monitor falls, track heart rhythms

For more than a decade, the latest Apple products have been the annual must-have holiday gift for the tech-savvy. That raises the question: Is the newest Apple Watch on your list — either to give or receive — this year?

4 Dec 2018

Biosense Webster treats first patient in U.S. IDE study of HELIOSTAR RF Balloon Ablation Catheter

Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its STELLAR U.S. Investigational Device Exemption study.

From Johnson & Johnson 4 Dec 2018

Clearer diagnosis of polio-like illness in young children

Johns Hopkins researchers have analyzed patient data from 45 cases of what they thought was acute flaccid myelitis, the polio-like outbreak occurring in U.S. children, and realized that only 75 percent of diagnosed cases were AFM.

4 Dec 2018

LetsGetChecked: The Company That's Revolutionizing Consumer Healthcare

LetsGetChecked is a medical technology platform revolutionizing consumer healthcare by linking patients with labs to make healthcare open and patient-led.

From Letsgetchecked 4 Dec 2018

CAR-T cell therapy appears to be promising option for treating large B-cell lymphoma

So-called CAR-T cell therapy is a promising option for treating around a fifth of patients with diffuse large B-cell lymphoma.

4 Dec 2018

Postmenopausal women who suffer tooth loss are at higher risk of hypertension

A new study in the American Journal of Hypertension indicates that postmenopausal women who have experienced tooth loss are at higher risk of developing high blood pressure. Multiple studies have suggested an association between periodontal disease and tooth loss with hypertension, but the relationship remains unclear.

4 Dec 2018

Aerobic exercise may reduce risk of diabetes-related renal disease

Aerobic exercise may reduce the risk of diabetes-related kidney disease in some people, according to a new study. The findings are published ahead of print in the American Journal of Physiology--Renal Physiology and was chosen as an APS select article for December.

4 Dec 2018

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

A new article published today in The Lancet Oncology shows 39 percent of large B cell lymphoma patients treated with the chimeric antigen receptor T-cell therapy Yescarta remained in remission more than two years following therapy, and more than half of the patients treated remain alive.

4 Dec 2018

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and effective.

4 Dec 2018

Blood News and Research

Successful delivery after womb transplant

Cancer cells could be detected irrespective of site and type using simple test

Single workout can improve metabolism for up to 2 days

Advances in gene therapy for inherited blood disorders

Study of infrequent cannabis users compares adverse effects of vaping and smoking

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

Cancer DNA signature will revolutionize point-of-care diagnostics

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Researchers find two connective tissue cells to be linked to worse prognosis of breast cancer

Scientists find link between dietary salt intake and risk of developing common heart condition

NanoBioCel group develops lipid vesicles that can genetic material efficiently and viably

In grandma’s stocking: An apple watch to monitor falls, track heart rhythms

Biosense Webster treats first patient in U.S. IDE study of HELIOSTAR RF Balloon Ablation Catheter

Clearer diagnosis of polio-like illness in young children

LetsGetChecked: The Company That's Revolutionizing Consumer Healthcare

CAR-T cell therapy appears to be promising option for treating large B-cell lymphoma

Postmenopausal women who suffer tooth loss are at higher risk of hypertension

Aerobic exercise may reduce risk of diabetes-related renal disease

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News